Skip to main content
Fig. 1 | BMC Medical Research Methodology

Fig. 1

From: Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma

Fig. 1

Long term overall survival of patients treated with bortezomib-based regimens for the PHAROS (registry) data and the NKR+ (registry) data, patients treated with MP-based regimens for the HOVON (RCT) data and the PHAROS (registry) data, and patients treated with thalidomide-based regimens for the HOVON (RCT) data and the PHAROS (registry) data

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us